NATURAL CAPSULES LIMITED (NATCAPSUQ) financials

NATURAL CAPSULES LIMITED (NATCAPSUQ) NSE/BSE financials on Fincrux: quarterly results, profit and loss, cash flow, balance sheet, ratios, and shareholding.

Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives[1]

Market Cap: ₹163Cr.
Current Price: ₹157
Stock P/E: 12.8
ROE: 6.48%
ROCE: 9.23%
Book Value: ₹173
Dividend Yield: 0.00%
52W High / Low: ₹237/136

In Jun 2026, NATURAL CAPSULES LIMITED (NATCAPSUQ) reported sales ₹43.02 Cr and net profit ₹4.04 Cr.

Annual TTM: sales ₹173 Cr, net profit ₹13 Cr.

Shareholding: Promoters 50.92% (Jun 2026), DIIs 0.00% (Jun 2026), Public 49.09% (Jun 2026), No. of Shareholders 8,756% (Jun 2026).

NATCAPSUQ quarterly results (₹ Cr.)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	41.03	43.41	44.36	44.24	44.58	34.15	50.80	43.02
Expenses	36.09	38.82	39.32	39.10	39.14	32.26	41.95	36.13
Operating Profit	4.94	4.59	5.04	5.14	5.44	1.89	8.85	6.89
OPM %	12.04%	10.57%	11.36%	11.62%	12.20%	5.53%	17.42%	16.02%
Other Income	0.77	1.15	1.55	1.69	1.73	2.11	2.13	2.31
Interest	1.54	1.39	1.52	1.36	1.45	1.45	1.49	1.44
Depreciation	2.16	2.14	1.94	1.99	2.02	2.09	2.06	2.10
Profit before tax	2.01	2.21	3.13	3.48	3.70	0.46	7.43	5.66
Tax %	54.23%	23.08%	16.29%	27.30%	24.05%	19.57%	25.71%	28.62%
Net Profit	0.92	1.70	2.63	2.52	2.81	0.36	5.52	4.04
EPS in Rs	0.90	1.64	2.54	2.44	2.72	0.35	5.31	3.88
Raw PDF	—	—	—	—	—	—	—	—

NATCAPSUQ profit and loss (₹ Cr.)
Category	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	62	80	135	171	153	168	174	173
Expenses	56	68	109	135	132	148	152	149
Operating Profit	5	11	26	36	21	19	22	23
OPM %	9%	14%	19%	21%	14%	12%	13%	13%
Other Income	1	3	1	1	3	4	8	8
Interest	1	1	2	4	5	6	6	6
Depreciation	4	4	5	7	9	8	8	8
Profit before tax	1	9	19	26	10	9	15	17
Tax %	38%	24%	28%	25%	25%	28%	26%	—
Net Profit	1	7	14	19	8	7	11	13
EPS in Rs	0.92	7.47	15.00	20.83	8.38	6.49	10.79	12.26
Dividend Payout %	43%	9%	5%	5%	0%	0%	0%	—

NATCAPSUQ balance sheet (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	6	6	6	7	9	9	10	10
Reserves	49	49	56	76	115	123	156	169
Borrowings	5	6	10	33	49	62	56	59
Other Liabilities	14	14	26	28	38	37	47	57
Total Liabilities	75	76	98	144	211	231	270	296
Fixed Assets	24	24	35	63	93	91	88	88
CWIP	2	2	3	1	0	2	0	2
Investments	5	6	0	0	20	23	23	23
Other Assets	43	45	60	80	98	116	159	184
Total Assets	75	76	98	144	211	231	270	296

NATCAPSUQ cash flows (₹ Cr.)
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	2	7	6	5	20	5	18	36
Cash from Investing Activity	-7	-6	-9	-30	-55	-11	-34	-34
Cash from Financing Activity	4	-1	3	27	34	7	15	-3
Net Cash Flow	-1	0	-0	1	-1	2	-2	-0
Free Cash Flow	-5	2	-11	-25	-16	-3	16	26
CFO/OP	57%	144%	72%	38%	72%	35%	103%	182%

NATCAPSUQ shareholding pattern (%)
Category	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	51.59%	51.13%	51.21%	51.26%	51.26%	51.26%	51.04%	50.92%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Public	48.39%	48.86%	48.80%	48.75%	48.73%	48.74%	48.96%	49.09%
No. of Shareholders	9,862	9,661	9,425	9,311	9,573	9,075	8,850	8,756

NATCAPSUQ key ratios
Category	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	197	180	123	71	111	128	137	129
Inventory Days	87	89	82	34	43	83	92	85
Days Payable	114	91	157	97	127	140	163	177
Cash Conversion Cycle	170	179	48	7	28	70	66	37
Working Capital Days	136	121	114	32	28	30	40	-3
ROCE %	5%	4%	11%	23%	20%	8%	7%	9%

NATCAPSUQUpdated 14 Oct 2026, 6:04

Natural Capsules Limited

NATCAPSUQUpdated 14 Oct 2026, 6:04

Market Cap

₹163Cr.

Current Price

₹157

High / Low

₹237/136

Stock P/E

12.8

ROE6.48%

ROCE9.23%

Book Value₹173

Face Value₹10.0

Dividend Yield0.00%

About

Incorporated in 1993, Natural Capsules manufactures Capsules and Steroidal APIs and their Intermediates and Derivatives[1]

Quarterly results

Last reported quarters₹ Cr.

Quarter	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Jun 2023	37.7	1.21	31.64	0.58	2.11	3.32	25.9	2.46	2.65
Sep 2023	37.52	1.15	32.28	0.61	2.16	2.54	22.44	1.97	2.12
Dec 2023	38.38	1.2	33.44	0.71	2.16	2.29	25.76	1.7	1.82
Mar 2024	40.2	1.38	35.7	1.26	2.14	2.24	24.55	1.69	1.81
Jun 2024	39.14	1.46	34.41	0.76	2.09	1.94	24.74	1.46	1.56
Sep 2024	41.03	1.54	36.09	0.77	2.16	2.01	54.23	0.92	0.9
Dec 2024	43.41	1.39	38.82	1.15	2.14	2.21	23.08	1.7	1.64
Mar 2025	44.36	1.52	39.32	1.55	1.94	3.13	16.29	2.63	2.54
Jun 2025	44.24	1.36	39.1	1.69	1.99	3.48	27.3	2.52	2.44
Sep 2025	44.58	1.45	39.14	1.73	2.02	3.7	24.05	2.81	2.72
Dec 2025	34.15	1.45	32.26	2.11	2.09	0.46	19.57	0.36	0.35
Mar 2026	50.8	1.49	41.95	2.13	2.06	7.43	25.71	5.52	5.31
Jun 2026	43.02	1.44	36.13	2.31	2.1	5.66	28.62	4.04	3.88

Profit & loss

Annual statement₹ Cr.

Year	Sales	Interest	Expenses	Other Income	Depreciation	Profit Before Tax	Tax	Net Profit	EPS (₹)
Mar 2015	67	1	56	1	4	8	25	6	7.15
Mar 2016	62	1	52	1	4	6	28	4	4.99
Mar 2017	54	1	49	0	4	0	-103	1	0.68
Mar 2018	55	0	49	1	4	2	34	1	1.19
Mar 2019	60	1	55	1	3	2	7	2	2.06
Mar 2020	62	1	56	1	4	1	38	1	0.92
Mar 2021	80	1	68	3	4	9	24	7	7.47
Mar 2022	135	2	109	1	5	19	28	14	15
Mar 2023	171	4	135	1	7	26	25	19	20.83
Mar 2024	153	5	132	3	9	10	25	8	8.38
Mar 2025	168	6	148	4	8	9	28	7	6.49
Mar 2026	174	6	152	8	8	15	26	11	10.79
TTM	173	6	149	8	8	17	—	13	12.26

Shareholding pattern

As of Jun 2026%

Holder	Share
Promoters	50.92%
Public	49.09%

Shareholding trend

Ownership over time%

Quarter	Promoters	DIIs	Public
Sep 2023	56.57%	1.31%	42.13%
Dec 2023	56.57%	1.31%	42.13%
Mar 2024	56.57%	1.31%	42.13%
Jun 2024	56.57%	0.18%	43.25%
Sep 2024	51.59%	0%	48.39%
Dec 2024	51.13%	0%	48.86%
Mar 2025	51.21%	0%	48.8%
Jun 2025	51.26%	0%	48.75%
Sep 2025	51.26%	0%	48.73%
Dec 2025	51.26%	0%	48.74%
Mar 2026	51.04%	0%	48.96%
Jun 2026	50.92%	0%	49.09%

Balance sheet

Assets & liabilities₹ Cr.

Period	Equity Capital	Reserves	Borrowings	Other Liabilities	Total Liabilities	Fixed Assets	CWIP	Investments	Other Assets	Total Assets
Mar 2015	5	42	5	11	63	29	2	0	32	63
Mar 2016	6	50	6	16	77	30	0	5	42	77
Mar 2017	6	48	3	14	71	26	0	5	40	71
Mar 2018	6	48	0	19	73	22	1	5	45	73
Mar 2019	6	49	5	14	75	24	2	5	43	75
Mar 2020	6	49	6	14	76	24	2	6	45	76
Mar 2021	6	56	10	26	98	35	3	0	60	98
Mar 2022	7	76	33	28	144	63	1	0	80	144
Mar 2023	9	115	49	38	211	93	0	20	98	211
Mar 2024	9	123	62	37	231	91	2	23	116	231
Mar 2025	10	156	56	47	270	88	0	23	159	270
Mar 2026	10	169	59	57	296	88	2	23	184	296

Cash flows

Operating, investing & financing₹ Cr.

Period	Operating	Investing	Financing	Net cash flow
Mar 2015	5	-4	-1	0
Mar 2016	3	-8	4	0
Mar 2017	2	0	-2	0
Mar 2018	5	-1	-4	0
Mar 2019	2	-7	4	-1
Mar 2020	7	-6	-1	0
Mar 2021	6	-9	3	0
Mar 2022	5	-30	27	1
Mar 2023	20	-55	34	-1
Mar 2024	5	-11	7	2
Mar 2025	18	-34	15	-2
Mar 2026	36	-34	-3	0

Key ratios

Historical financial ratios

Category	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	125	167	191	208	197	180	123	71	111	128	137	129
Inventory Days	66	147	119	149	87	89	82	34	43	83	92	85
Days Payable	74	148	159	185	114	91	157	97	127	140	163	177
Cash Conversion Cycle	117	166	151	172	170	179	48	7	28	70	66	37
Working Capital Days	87	123	155	186	136	121	114	32	28	30	40	-3
ROCE %	17%	12%	3%	4%	5%	4%	11%	23%	20%	8%	7%	9%

Frequently asked questions

Quick answers about this company's financials on Fincrux

What is the market cap of NATURAL CAPSULES LIMITED (NATCAPSUQ)?

The reported market capitalisation for NATURAL CAPSULES LIMITED (NATCAPSUQ) is ₹163Cr. on Fincrux. Figures may update with market data and filings.

What is the current share price of NATCAPSUQ?

The current price shown for NATURAL CAPSULES LIMITED (NATCAPSUQ) on Fincrux is ₹157 with a 52-week high/low of ₹237/136.

What is the P/E ratio of NATURAL CAPSULES LIMITED (NATCAPSUQ)?

The stock P/E for NATURAL CAPSULES LIMITED (NATCAPSUQ) is 12.8 on Fincrux, with ROE at 6.48% and ROCE at 9.23%.

What were NATCAPSUQ latest quarterly results?

For Jun 2026, NATURAL CAPSULES LIMITED (NATCAPSUQ) reported sales ₹43.02 Cr and net profit ₹4.04 Cr (figures in ₹ crore unless noted).

What are NATCAPSUQ annual sales and net profit?

For TTM, NATURAL CAPSULES LIMITED (NATCAPSUQ) shows sales of ₹173 Cr and net profit of ₹13 Cr on the Fincrux profit & loss statement.

Who owns NATURAL CAPSULES LIMITED (NATCAPSUQ)?

Latest shareholding for NATURAL CAPSULES LIMITED (NATCAPSUQ) on Fincrux: Promoters 50.92% (Jun 2026), DIIs 0.00% (Jun 2026), Public 49.09% (Jun 2026), No. of Shareholders 8,756% (Jun 2026).

Where can I find NATURAL CAPSULES LIMITED (NATCAPSUQ) financials?

NATURAL CAPSULES LIMITED (NATCAPSUQ) financials on Fincrux include quarterly results, profit and loss, cash flow, balance sheet, key ratios, and shareholding patterns for NSE/BSE research.

Does Fincrux show NATCAPSUQ balance sheet and cash flow?

Yes. The NATURAL CAPSULES LIMITED (NATCAPSUQ) page on Fincrux includes balance sheet, cash flow statements, historical ratios, and ownership trends alongside quarterly and annual results.

Figures in ₹ crore unless noted. Data sourced for research and may lag filings.

Last updated 14 October 2026 at 6:04